Security key
N5436L101
MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (MYNZ)
CUSIP: N5436L101
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Ordinary Shares, (euro)0.01 nominal value
- Shares outstanding
- 489,733,060
- Total 13F shares
- 20,149
- Share change
- +1,072
- Total reported value
- $59,220
- Price per share
- $2.92
- Number of holders
- 8
- Value change
- +$2,938
- Number of buys
- 1
- Number of sells
- 4
Report period
Q3 2023
Institutions
8
Top holders
8
MYNZ full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Quantum Cyber N.V. SEC filings
Quantum Cyber N.V. company facts
Broader feeds
Reporting periods
Holder history for CUSIP N5436L101
Recent filing periods:
Top shareholders of MYNZ - MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Greenwich Investment Management, Inc. |
13F
|
Company |
0%
|
14,159
|
$67,000 | — | 30 Jun 2023 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
1,500
|
$7,170 | — | 30 Jun 2023 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
1,000
|
$4,780 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
931
|
$4,450 | — | 30 Jun 2023 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
673
|
$3,217 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
500
|
$2,390 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
200
|
$956 | — | 30 Jun 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
100
|
$478 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
14
|
$67 | — | 30 Jun 2023 |
Institutional Holders of MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (MYNZ) as of Q3 2023
As of 30 Sep 2023,
MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (MYNZ) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,149 shares.
The largest 8 holders included
Greenwich Investment Management, Inc., JPMORGAN CHASE & CO, Steward Partners Investment Advisory, LLC, NewEdge Advisors, LLC, CITIGROUP INC, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, and UBS Group AG.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
9
Q3 2023 holders
8
Holder diff
-1
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.